Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application
Molecules · 17.04.2023 · 28 (8) · 3539
DOI: 10.3390/molecules28083539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 17.04.2023. Verfasst von Nana Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Thymosin, Acquired Immunodeficiency Syndrome. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Zhejiang Provincial Natural Science Foundation of China, opening fund of the State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Zhejiang Provincial Key Laboratory Project.
Abstract (Originalsprache)
Thymosin α1 (Tα1) is an immunostimulatory peptide that is commonly used as an immune enhancer in viral infectious diseases such as hepatitis B, hepatitis C, and acquired immune deficiency syndrome (AIDS). Tα1 can influence the functions of immune cells, such as T cells, B cells, macrophages, and natural killer cells, by interacting with various Toll-like receptors (TLRs). Generally, Tα1 can bind to TLR3/4/9 and activate downstream IRF3 and NF-κB signal pathways, thus promoting the proliferation and activation of target immune cells. Moreover, TLR2 and TLR7 are also associated with Tα1. TLR2/NF-κB, TLR2/p38MAPK, or TLR7/MyD88 signaling pathways are activated by Tα1 to promote the production of various cytokines, thereby enhancing the innate and adaptive immune responses. At present, there are many reports on the clinical application and pharmacological research of Tα1, but there is no systematic review to analyze its exact clinical efficacy in these viral infectious diseases via its modulation of immune function. This review offers an overview and discussion of the characteristics of Tα1, its immunomodulatory properties, the molecular mechanisms underlying its therapeutic effects, and its clinical applications in antiviral therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macao 999078, China.
ORCID-Profile: Jianli Gao
Förderung
- the Zhejiang Provincial Natural Science Foundation of China
- opening fund of the State Key Laboratory of Quality Research in Chinese Medicine, University of Macau
- Zhejiang Provincial Key Laboratory Project
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- State Key Laboratory of Quality Research in Chinese Medicine, University of Macau
Zitieren
APA
Tao, N., Xu, X., Ying, Y., Hu, S., Sun, Q., Lv, G., & Gao, J. (2023). Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules, 28(8), 3539. https://doi.org/10.3390/molecules28083539
Vancouver
Tao N, Xu X, Ying Y, Hu S, Sun Q, Lv G, et al. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules. 2023;28(8):3539. doi:10.3390/molecules28083539
BibTeX
@article{Tao2023,
author = {Tao, Nana and Xu, Xie and Ying, Yuyuan and Hu, Shiyu and Sun, Qingru and Lv, Guiyuan and Gao, Jianli},
title = {Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application},
journal = {Molecules},
year = {2023},
volume = {28},
number = {8},
pages = {3539},
doi = {10.3390/molecules28083539}
}
EUVIMED